NASDAQ: AUTL - Autolus Therapeutics plc

Rentabilidade por seis meses: -54.4%
Rendimento de dividendos: 0.00%
Setor: Healthcare

Notícias
Blackstone to invest up to $250 million in Autolus Therapeutics of U.K.

18 novembro 17:59 Blackstone to invest up to $250 million in Autolus Therapeutics of U.K.